Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Zhang, Zhen ^a   Gao, Wei ^b   Long, Qing Qing ^a   Zhang, Jian ^a   Li, Ya Fei ^a   Liu, Dong Chen ^a   Yan, Jian Jun ^a   Yang, Zhi Jian ^a   Wang, Lian Sheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; H19 LONG NON-CODING RNA; LONG UNTRANSLATED RNA;

ADULT; AGED; AREA UNDER THE CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; ETHNOLOGY; FEMALE; GENETICS; HEART ATRIUM REMODELING; HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK; STATISTICAL MODEL;

ADULT; AGED; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL REMODELING; BIOMARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK; RNA, LONG NONCODING; ROC CURVE; VENTRICULAR REMODELING;

EID: 85027155445     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-07611-z     Document Type: Article

References (38)

1. Mozaffarian, D. et al. Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation 133, 447-454, doi:10.1161/CIR.0000000000000366 (2016).
2. Dalen, J. E., Alpert, J. S., Goldberg, R. J. & Weinstein, R. S. The epidemic of the 20(th) century: coronary heart disease. Am J Med 127, 807-812, doi:10.1016/j.amjmed.2014.04.015 (2014).
3. Steg, P. G. & Ducrocq, G. Future of the Prevention and Treatment of Coronary Artery Disease. Circ J 80, 1067-1072, doi:10.1253/circj.CJ-16-0266 (2016).
4. Young, R. S. & Ponting, C. P. Identification and function of long non-coding RNAs. Essays Biochem 54, 113-126, doi:10.1042/bse0540113 (2013).
5. Kaikkonen, M. U., Lam, M. T. & Glass, C. K. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 90, 430-440, doi:10.1093/cvr/cvr097 (2011).
6. Robbins, C. S. et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19, 1166-1172, doi:10.1038/nm.3258 (2013).
7. Wronska, A., Kurkowska-Jastrzebska, I. & Santulli, G. Application of microRNAs in diagnosis and treatment of cardiovascular disease. Acta Physiol (Oxf) 213, 60-83, doi:10.1111/apha.12416 (2015).
8. Greco, S., Gorospe, M. & Martelli, F. Noncoding RNA in age-related cardiovascular diseases. J Mol Cell Cardiol 83, 142-155, doi:10.1016/j.yjmcc.2015.01.011 (2015).
9. Novak, J., Olejnickova, V., Tkacova, N. & Santulli, G. Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis. Adv Exp Med Biol 887, 79-100, doi:10.1007/978-3-319-22380-3-5 (2015).
10. Haloom, R. & Assam, E.-O. HDAC Inhibition in Vascular Endothelial Cells Regulates the Expression of ncRNAs. Non-Coding RNA 2, 4 (2016).
11. Han, D. K., Khaing, Z. Z., Pollock, R. A., Haudenschild, C. C. & Liau, G. H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. J Clin Invest 97, 1276-1285, doi:10.1172/JCI118543 (1996).
12. Kim, D. K., Zhang, L., Dzau, V. J. & Pratt, R. E. H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury. J Clin Invest 93, 355-360, doi:10.1172/JCI116967 (1994).
13. Cui, M. et al. Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway. Cancer Res 75, 846-857, doi:10.1158/0008-5472.CAN-14-1192 (2015).
14. Halley, P. et al. Regulation of the apolipoprotein gene cluster by a long noncoding RNA. Cell Rep 6, 222-230, doi:10.1016/j. celrep.2013.12.015 (2014).
15. Li, Z. et al. The long noncoding RNA THRIL regulates TNFalpha expression through its interaction with hnRNPL. Proc Natl Acad Sci USA 111, 1002-1007, doi:10.1073/pnas.1313768111 (2014).
16. Gao, W. et al. Altered long noncoding RNA expression profiles in the myocardium of rats with ischemic heart failure. J Cardiovasc Med (Hagerstown) 16, 473-479, doi:10.2459/JCM.0b013e32836499cd (2015).
17. Busch, A., Eken, S. M. & Maegdefessel, L. Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease. Ann Transl Med 4, 236, doi:10.21037/atm.2016.06.06 (2016).
18. Gao, W. et al. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis 11, 55, doi:10.1186/1476-511X-11-55 (2012).
19. Kumarswamy, R. et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res 114, 1569-1575, doi:10.1161/CIRCRESAHA.114.303915 (2014).
20. Song, C. et al. Construction and analysis of cardiac hypertrophy-associated lncRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in cardiac hypertrophy. Oncotarget 7, 10827-10840, doi:10.18632/oncotarget.7312 (2016).
21. Carpenter, S. et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 341, 789-792, doi:10.1126/science.1240925 (2013).
22. He, C. et al. The Role of Long Intergenic Noncoding RNA p21 in Vascular Endothelial Cells. DNA Cell Biol 34, 677-683, doi:10.1089/ dna.2015.2966 (2015).
23. Gensini, G. G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51, 606 (1983).
24. Wang, L. S. et al. A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease. Mol Biol Rep 38, 819-825, doi:10.1007/s11033-010-0171-6 (2011).
25. Yancy, C. W. et al. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 134, e282-293, doi:10.1161/CIR.0000000000000435 (2016).
26. Liu, L. et al. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Cardiovasc Res 111, 56-65, doi:10.1093/cvr/cvw078 (2016).
27. Gabory, A., Ripoche, M. A., Yoshimizu, T. & Dandolo, L. The H19 gene: regulation and function of a non-coding RNA. Cytogenet Genome Res 113, 188-193, doi:10.1159/000090831 (2006).
28. Wang, K. C. et al. Fetal growth restriction and the programming of heart growth and cardiac insulin-like growth factor 2 expression in the lamb. J Physiol 589, 4709-4722, doi:10.1113/jphysiol.2011.211185 (2011).
29. Descartes, M., Romp, R., Franklin, J., Biggio, J. R. & Zehnbauer, B. Constitutional H19 hypermethylation in a patient with isolated cardiac tumor. Am J Med Genet A 146A, 2126-2129, doi:10.1002/ajmg.a.32421 (2008).
30. Devlin, A. M., Bottiglieri, T., Domann, F. E. & Lentz, S. R. Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J Biol Chem 280, 25506-25511, doi:10.1074/jbc.M504815200 (2005).
31. Li, L., Xie, J., Zhang, M. & Wang, S. Homocysteine harasses the imprinting expression of IGF2 and H19 by demethylation of differentially methylated region between IGF2/H19 genes. Acta Biochim Biophys Sin (Shanghai) 41, 464-471 (2009).
32. Pan, J. X. LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. Eur Rev Med Pharmacol Sci 21, 322-328 (2017).
33. Gao, W. et al. Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population. Mutat Res 772, 15-22, doi:10.1016/j.mrfmmm.2014.12.009 (2015).
34. Nordin, M., Bergman, D., Halje, M., Engstrom, W. & Ward, A. Epigenetic regulation of the Igf2/H19 gene cluster. Cell Prolif 47, 189-199, doi:10.1111/cpr.12106 (2014).
35. Wilkin, F. et al. H19 sense and antisense transgenes modify insulin-like growth factor-II mRNA levels. Eur J Biochem 267, 4020-4027 (2000).
36. Christiansen, J., Kolte, A. M., Hansen, T. & Nielsen, F. C. IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. J Mol Endocrinol 43, 187-195, doi:10.1677/JME-09-0016 (2009).
37. Greco, S. et al. Long noncoding RNA dysregulation in ischemic heart failure. J Transl Med 14, 183, doi:10.1186/s12967-016-0926-5 (2016).
38. de Gonzalo-Calvo, D. et al. Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes. Sci Rep 6, 37354, doi:10.1038/srep37354 (2016).